At the 2024 Society for Neuro-Oncology Annual Meeting, SurvivorNet Connect sat down with a panel of experts from across the field to discuss the latest updates, approvals, and treatment options — including the exciting approval of vorasidenib (Voranigo) to treat patients with IDH1/2-mutated diffuse glioma. The panel features some of the country’s leading researchers and […]
Each year, SurvivorNet hosts a special virtual conference focused on racial disparities and ways to establish trust with patients. Top doctors offered training on how to avoid provider bias, discussed ways to effectively reduce disparities in multiple myeloma, and gave practical advice and solutions on how doctors can better serve communities of color, including clinical […]
SurvivorNet held a collaborative conversation where opinion leaders shared what’s changed when it comes to treating multiple myeloma, the latest in new practices and protocols — and what the future may look like.
Cancer treatment protocols and best practices are ever-evolving and there have been some major changes in the ovarian cancer space in just the past few years alone.
Online Video Conference
Sign Up for SN Connect
Join SN Connect for access to the latest clinical tools, research updates, and expert insights across specialties
Personalized clinical content tailored to your specialty and patient demographics
Comprehensive treatment guides and case studies for evidence-based care
Real-time updates on therapeutic advancements and expert analyses